洛伦德罗斯塔特用于患有失控高血压的患者:系统性审查与元分析和试验序列分析
Vicente Morales Ribeiro1, Douglas Nunes Cavalcante2, Hermes Estevam Torega Celkevicius3
1Department of Internal Medicine, University of Southern Santa Catarina, Palhoça, Brazil.
American journal of hypertension
|December 22, 2025
概括
洛伦德洛斯塔特有效降低患有失控高血压的患者的血压,但增加了高血的风险. 需要进一步的试验来确认与现有治疗相比,其长期的安全性和有效性.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 没有控制的高血压会给健康带来重大风险.
- 作为选择性阿尔多氨酸合成酶抑制剂的洛伦德罗斯塔特的疗效和安全性尚未得到充分证实.
- 这一元分析评估了洛伦德罗斯塔特对血压和高血症风险的影响.
研究的目的:
- 为了评估洛伦德罗斯塔特的降血压效果.
- 为了确定与洛伦德罗斯塔特治疗相关的高卡利米亚风险.
- 评估洛伦德罗斯塔特在治疗失控高血压方面的安全性和有效性.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和ClinicalTrials.gov.gov的系统搜索中进行了系统的搜索.
- 包括三项随机对照试验 (RCT),比较洛伦德洛斯塔特与安慰剂.
- 随机效应元分析和试验序列分析 (TSA) 进行可靠的证据评估.
主要成果:
- 洛伦德洛斯塔特显著降低了静缩和静缩血压,以剂量依赖的方式.
- 随着50mg和100mg剂量的洛伦德罗斯塔特,观察到高胆固醇血风险的显著增加.
- 美国运输安全局确定100mg的高血是确的危害信号;其他安全结果是不确的.
结论:
- 洛伦德洛斯塔特在降低无控高血压的血压方面表现出有效性.
- 过高血风险的剂量依赖性增加需要仔细监测.
- 需要进一步的研究,包括长期结局试验和与矿物质皮质醇受体抗剂的比较.
相关概念视频
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
564
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
564
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437
01:23Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K